Phase I, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of NI-0401 (a Fully Human Anti-CD3 Monoclonal Antibody) in Patients with Moderate to Severe Active Crohn's Disease

C.J. van der Woude, P. Stokkers, A.A. van Bodegraven, G. Van Assche, Z. Hebzda, L. Paradowski, G d'Haens, S. Ghosh, B. Feagan, P. Rutgeerts, G. Dijkstra, D.J. Jong, B. Oldenburg, M. Farhan, T. Richard, Y. Dean, D.W. Hommes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1708-1716
JournalInflammatory Bowel Diseases
Issue number10
Publication statusPublished - 2010

Cite this